LINC02317

Across TCGA pan-cancer cohorts, LINC02317 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02317’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC02317 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02317 is over-expressed in tumor.

HNSC and BLCA are the cancer types where LINC02317 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02317 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+0.098	<.001	8	view →
BLCA	All	All	+0.088	.039	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC02317–HNSC

Open the HNSC breakdown →